A randomized, open-label, crossover study comparing the effects of oral versus transdermal estrogen therapy on serum androgens, thyroid hormones, and adrenal hormones in naturally menopausal women
- PMID: 17507833
- DOI: 10.1097/gme.0b013e31803867a
A randomized, open-label, crossover study comparing the effects of oral versus transdermal estrogen therapy on serum androgens, thyroid hormones, and adrenal hormones in naturally menopausal women
Abstract
Objective: To compare the changes induced by oral versus transdermal estrogen therapy on the total and free serum concentrations of testosterone (T), thyroxine (T4), and cortisol (C) and the concentrations of their serum binding globulins sex hormone-binding globulin, thyroxine-binding globulin, and cortisol-binding globulin in naturally menopausal women.
Design: Randomized, open-label, crossover. Interventions included a 6-week withdrawal from previous hormone therapy (baseline), followed in randomized order by 12 weeks of oral conjugated equine estrogens (CEE) (0.625 mg/d) and 12 weeks of transdermal estradiol (TD E2) (0.05 mg/d), with oral micronized progesterone (100 mg/d) given continuously during both transdermal estrogen therapy regimens.
Results: Twenty-seven women were enrolled in the study, and 25 completed both treatment periods. The mean(SD) percentage changes from baseline of sex hormone-binding globulin, total T, and free T with oral CEE were +132.1% (74.5%), +16.4% (43.8%), and -32.7% (25.9%), respectively, versus +12.0% (25.1%), +1.2% (43.7%), and +1.0% (45.0%) with TD E2. The mean (SD) percentage changes of thyroxine-binding globulin, total T4, and free T4 with oral CEE were +39.9% (20.1%), +28.4% (29.2%), and -10.4% (22.3%), respectively, versus +0.4% (11.1%), -0.7% (16.5%), and +0.2% (26.6%) with TD E2. The mean (SD) percentage changes of cortisol-binding globulin, total C, and free C with oral CEE were +18.0% (19.5%), +29.2% (46.3%), and +50.4% (126.5%), respectively, versus -2.2% (11.3%), -6.7% (30.8%), and +1.8% (77.1%) with TD E2. Concentrations of all hormones and binding globulins were significantly different (P < or = 0.003) during administration of oral versus transdermal estrogen therapy, except for free T4 and free C.
Conclusions: Compared with oral CEE, TD E2 exerts minimal effects on the total and free concentrations of T, T4, and C and their binding proteins.
Comment in
-
Parenteral versus oral treatment of postmenopausal women with estrogen.Menopause. 2007 Nov-Dec;14(6):968-70. doi: 10.1097/gme.0b013e318157c0c9. Menopause. 2007. PMID: 17898669 No abstract available.
Similar articles
-
A comparison of the short-term effects of oral conjugated equine estrogens versus transdermal estradiol on C-reactive protein, other serum markers of inflammation, and other hepatic proteins in naturally menopausal women.J Clin Endocrinol Metab. 2008 May;93(5):1702-10. doi: 10.1210/jc.2007-2193. Epub 2008 Feb 26. J Clin Endocrinol Metab. 2008. PMID: 18303079 Clinical Trial.
-
Effects of four different regimens of hormone replacement therapy on hemostatic parameters: a prospective randomized study.Maturitas. 2006 Feb 20;53(3):267-73. doi: 10.1016/j.maturitas.2005.05.010. Epub 2005 Jun 22. Maturitas. 2006. PMID: 15978753 Clinical Trial.
-
Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus.Climacteric. 2002 Sep;5(3):286-92. Climacteric. 2002. PMID: 12419087 Clinical Trial.
-
Hormone replacement therapy in menopausal women: Past problems and future possibilities.Gynecol Endocrinol. 2006 Oct;22(10):564-77. doi: 10.1080/09513590600927017. Gynecol Endocrinol. 2006. PMID: 17135036 Review.
-
Transdermal delivery of sex steroids for hormone replacement therapy and contraception. A review of principles and practice.J Reprod Med. 2003 Jul;48(7):525-40. J Reprod Med. 2003. PMID: 12953327 Review.
Cited by
-
Body composition and bone mineral density after ovarian hormone suppression with or without estradiol treatment.Menopause. 2015 Oct;22(10):1045-52. doi: 10.1097/GME.0000000000000430. Menopause. 2015. PMID: 25783468 Free PMC article. Clinical Trial.
-
Factors influencing the levothyroxine dose in the hormone replacement therapy of primary hypothyroidism in adults.Rev Endocr Metab Disord. 2022 Jun;23(3):463-483. doi: 10.1007/s11154-021-09691-9. Epub 2021 Oct 20. Rev Endocr Metab Disord. 2022. PMID: 34671932 Free PMC article. Review.
-
Daily salivary cortisol patterns in midlife women with hot flashes.Clin Endocrinol (Oxf). 2016 May;84(5):672-9. doi: 10.1111/cen.12995. Epub 2016 Jan 26. Clin Endocrinol (Oxf). 2016. PMID: 26663024 Free PMC article. Clinical Trial.
-
International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women.J Womens Health (Larchmt). 2021 Apr;30(4):474-491. doi: 10.1089/jwh.2021.29037. Epub 2021 Apr 1. J Womens Health (Larchmt). 2021. PMID: 33797277 Free PMC article.
-
Effects of estrogen versus estrogen and progesterone on cortisol and interleukin-6.Maturitas. 2008 Dec 20;61(4):330-3. doi: 10.1016/j.maturitas.2008.09.024. Epub 2008 Nov 17. Maturitas. 2008. PMID: 19010617 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources